Evidence map›Paper›PMID 35925943›Full record

ArticlePloS one2022

Achieving the 95 95 95 targets for all: A pathway to ending AIDS.

Luisa Frescura, Peter Godfrey-Faussett, Ali Feizzadeh A, Wafaa El-Sadr, Omar Syarif, Peter D Ghys, on and behalf of the 2025 testing treatment target Working Group

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 277 papers, 12 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
277citing papers in PubMed, 12 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

277 citing papers in PubMed, 12 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

217 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Luisa FrescuraStrategic Information Department, UNAIDS, Geneva, Switzerland.ORCID 0000-0002-2089-7818
Peter Godfrey-FaussettStrategic Information Department, UNAIDS, Geneva, Switzerland.
Ali Feizzadeh A *Strategic Information Department, UNAIDS, Geneva, Switzerland.
Wafaa El-SadrICAP at Columbia University, Mailman School of Public Health, New York, New York, United States of America.
Omar SyarifGlobal Network of People Network Living with HIV (GNP+), Gardens, South Africa.
Peter D GhysStrategic Information Department, UNAIDS, Geneva, Switzerland.
on and behalf of the 2025 testing treatment target Working Group

Funding

Medical Research Council MR/R015600/1
6 · The paper itself

Abstract

In December 2020, UNAIDS released a new set of ambitious targets calling for 95% of all people living with HIV to know their HIV status, 95% of all people with diagnosed HIV infection to receive sustained antiretroviral therapy, and 95% of all people receiving antiretroviral therapy to have viral suppression by 2025. Adopted by United Nations Member states in June 2021 as part of the new Political Declaration on HIV and AIDS, these targets, combined with ambitious primary prevention targets and focused attention to supporting enablers, aim to bridge inequalities in treatment coverage and outcomes and accelerate HIV incidence reductions by focusing on progress in all sub-populations, age groups and geographic settings. Here we summarise the evidence and decisions underpinning the new global targets.

Indexed as

Acquired Immunodeficiency SyndromeHIV InfectionsHIV TestingHumansIncidenceUnited Nations

Identifiers

PMID35925943
PMCPMC9352102

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.